메뉴 건너뛰기




Volumn 18, Issue 2, 2009, Pages 209-215

Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives

Author keywords

BRCA; Cancer; Genetic testing; Inconclusive; Oncology

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

EID: 66149158276     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1407     Document Type: Article
Times cited : (26)

References (19)
  • 2
    • 38349055057 scopus 로고    scopus 로고
    • Genetic testing for familial cancer. The French National Report (year 2003)
    • Eisinger F. Genetic testing for familial cancer. The French National Report (year 2003). Community Genet 2008;11(1):63-67.
    • (2008) Community Genet , vol.11 , Issue.1 , pp. 63-67
    • Eisinger, F.1
  • 3
    • 11144356022 scopus 로고    scopus 로고
    • Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)
    • Eisinger F, Bressac B, Castaigne D et al. Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 2004;91(3):219-237.
    • (2004) Bull Cancer , vol.91 , Issue.3 , pp. 219-237
    • Eisinger, F.1    Bressac, B.2    Castaigne, D.3
  • 4
    • 30344455342 scopus 로고    scopus 로고
    • No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result
    • Dorval M, Gauthier G, Maunsell E et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 2005;14(12):2862-2867.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , Issue.12 , pp. 2862-2867
    • Dorval, M.1    Gauthier, G.2    Maunsell, E.3
  • 5
    • 18344367085 scopus 로고    scopus 로고
    • What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer
    • van Dijk S, Otten W, Timmermans DR et al. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 2005;7(4):239-245.
    • (2005) Genet Med , vol.7 , Issue.4 , pp. 239-245
    • van Dijk, S.1    Otten, W.2    Timmermans, D.R.3
  • 6
    • 33747040585 scopus 로고    scopus 로고
    • Clinical characteristics affect the impact of an uninformative DNA-test result: The course of worry and distress experienced by women who apply for genetic testing for breast cancer
    • van Dijk S, Timmermans DRM, Meijers-Heijboer EJ, Tibben A, van Asperen CJ, Otten W. Clinical characteristics affect the impact of an uninformative DNA-test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol 2006;24:3672-3677.
    • (2006) J Clin Oncol , vol.24 , pp. 3672-3677
    • van Dijk, S.1    Timmermans, D.R.M.2    Meijers-Heijboer, E.J.3    Tibben, A.4    van Asperen, C.J.5    Otten, W.6
  • 7
    • 0037380994 scopus 로고    scopus 로고
    • Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method
    • Hogervorst FB, Nederlof PM, Gille JJ et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003;63(7):1449-1453.
    • (2003) Cancer Res , vol.63 , Issue.7 , pp. 1449-1453
    • Hogervorst, F.B.1    Nederlof, P.M.2    Gille, J.J.3
  • 8
    • 33645084562 scopus 로고    scopus 로고
    • Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
    • Walsh T, Casadei S, Coats KH et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. J Am Med Assoc 2006;295(12):1379-1388.
    • (2006) J Am Med Assoc , vol.295 , Issue.12 , pp. 1379-1388
    • Walsh, T.1    Casadei, S.2    Coats, K.H.3
  • 9
    • 33744818935 scopus 로고    scopus 로고
    • A literature review of the psychological impact of genetic testing on breast cancer patients
    • Schlich-Bakker KJ, Ten Kroode HF, Ausems MG. A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 2006;62(1):13-20.
    • (2006) Patient Educ Couns , vol.62 , Issue.1 , pp. 13-20
    • Schlich-Bakker, K.J.1    Ten Kroode, H.F.2    Ausems, M.G.3
  • 10
    • 0036591549 scopus 로고    scopus 로고
    • Genetic testing for women previously diagnosed with breast/ovarian cancer: Examining the impact of BRCA1 and BRCA2 mutation searching
    • Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test 2002;6(2):79-87.
    • (2002) Genet Test , vol.6 , Issue.2 , pp. 79-87
    • Hallowell, N.1    Foster, C.2    Ardern-Jones, A.3    Eeles, R.4    Murday, V.5    Watson, M.6
  • 11
    • 0042319194 scopus 로고    scopus 로고
    • Communication of BRCA1 and BRCA2 results to at-risk relatives: A cancer risk assessment program's experience
    • Wagner Costalas J, Itzen M, Malick J et al. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Am J Med Genet C Semin Med Genet 2003; 119(1):11-18.
    • (2003) Am J Med Genet C Semin Med Genet , vol.119 , Issue.1 , pp. 11-18
    • Wagner Costalas, J.1    Itzen, M.2    Malick, J.3
  • 12
    • 7844223656 scopus 로고    scopus 로고
    • Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee
    • Eisinger F, Alby N, Bremond A et al. Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee. Ann Oncol 1998;9(9):939-950.
    • (1998) Ann Oncol , vol.9 , Issue.9 , pp. 939-950
    • Eisinger, F.1    Alby, N.2    Bremond, A.3
  • 13
    • 2942726188 scopus 로고    scopus 로고
    • A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCA-PRO
    • Evans DG, Eccles DM, Rahman N et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCA-PRO. J Med Genet 2004;41(6):474-480.
    • (2004) J Med Genet , vol.41 , Issue.6 , pp. 474-480
    • Evans, D.G.1    Eccles, D.M.2    Rahman, N.3
  • 14
    • 0024403272 scopus 로고
    • La version française de l'échelle de CES-D (Center for Epidemiologic Studies - Depression Scale). Description et traduction de l'échelle d'autoévaluation.
    • Fuhrer R, Rouillon F. La version française de l'échelle de CES-D (Center for Epidemiologic Studies - Depression Scale). Description et traduction de l'échelle d'autoévaluation. Psychiatr Psychobiol 1989;4: 163-166.
    • (1989) Psychiatr Psychobiol , vol.4 , pp. 163-166
    • Fuhrer, R.1    Rouillon, F.2
  • 15
    • 0018777479 scopus 로고
    • Impact of event scale: A measure of subjective stress
    • Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41(3):209.
    • (1979) Psychosom Med , vol.41 , Issue.3 , pp. 209
    • Horowitz, M.1    Wilner, N.2    Alvarez, W.3
  • 18
    • 2442521134 scopus 로고    scopus 로고
    • Accommodating risk: Responses to BRCA1/2 genetic testing of women who had cancer
    • Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Accommodating risk: responses to BRCA1/2 genetic testing of women who had cancer. Soc Sci Med 2003;59(3):553-565.
    • (2003) Soc Sci Med , vol.59 , Issue.3 , pp. 553-565
    • Hallowell, N.1    Foster, C.2    Eeles, R.3    Ardern-Jones, A.4    Watson, M.5
  • 19
    • 13144276270 scopus 로고    scopus 로고
    • Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics
    • Julian-Reynier C, Eisinger F, Chabal F et al. Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics. Oncol Rep 1998;5(4): 885-888.
    • (1998) Oncol Rep , vol.5 , Issue.4 , pp. 885-888
    • Julian-Reynier, C.1    Eisinger, F.2    Chabal, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.